LH Quote, Financials, Valuation and Earnings

Danaher has a net margin of 6.36% compared to Labcorp Holdings's net margin of 16.62%. Labcorp Holdings's return on equity of 9.01% beat Danaher's return on equity of 7.38%.

Labcorp Holdings has a consensus price target of $271.13, signalling upside risk potential of 12.37%. On the other hand Danaher has an analysts' consensus of $247.17 which suggests that it could grow by 25.65%. Given that Danaher has higher upside potential than Labcorp Holdings, analysts believe Danaher is more attractive than Labcorp Holdings.

Labcorp Holdings has a beta of 0.826, which suggesting that the stock is 17.43% less volatile than S&P 500. In comparison Danaher has a beta of 0.804, suggesting its less volatile than the S&P 500 by 19.561%.

Labcorp Holdings has a quarterly dividend of $0.72 per share corresponding to a yield of 1.19%. Danaher offers a yield of 0.58% to investors and pays a quarterly dividend of $0.32 per share. Labcorp Holdings pays 32.59% of its earnings as a dividend. Danaher pays out 19.7% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Labcorp Holdings quarterly revenues are $3.3B, which are smaller than Danaher quarterly revenues of $5.7B. Labcorp Holdings's net income of $212.8M is lower than Danaher's net income of $954M. Notably, Labcorp Holdings's price-to-earnings ratio is 27.89x while Danaher's PE ratio is 38.20x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Labcorp Holdings is 1.54x versus 6.03x for Danaher. Usually stocks with elevated PS ratios are considered overvalued.

Exact Sciences has a net margin of 6.36% compared to Labcorp Holdings's net margin of -121.19%. Labcorp Holdings's return on equity of 9.01% beat Exact Sciences's return on equity of -34.11%.

Labcorp Holdings has a consensus price target of $271.13, signalling upside risk potential of 12.37%. On the other hand Exact Sciences has an analysts' consensus of $66.85 which suggests that it could grow by 41.76%. Given that Exact Sciences has higher upside potential than Labcorp Holdings, analysts believe Exact Sciences is more attractive than Labcorp Holdings.

Labcorp Holdings has a beta of 0.826, which suggesting that the stock is 17.43% less volatile than S&P 500. In comparison Exact Sciences has a beta of 0.920, suggesting its less volatile than the S&P 500 by 7.968%.

Labcorp Holdings has a quarterly dividend of $0.72 per share corresponding to a yield of 1.19%. Exact Sciences offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Labcorp Holdings pays 32.59% of its earnings as a dividend. Exact Sciences pays out -- of its earnings as a dividend. Labcorp Holdings's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Labcorp Holdings quarterly revenues are $3.3B, which are larger than Exact Sciences quarterly revenues of $713.4M. Labcorp Holdings's net income of $212.8M is higher than Exact Sciences's net income of -$864.6M. Notably, Labcorp Holdings's price-to-earnings ratio is 27.89x while Exact Sciences's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Labcorp Holdings is 1.54x versus 3.15x for Exact Sciences. Usually stocks with elevated PS ratios are considered overvalued.

Illumina has a net margin of 6.36% compared to Labcorp Holdings's net margin of 16.94%. Labcorp Holdings's return on equity of 9.01% beat Illumina's return on equity of -35.09%.

Labcorp Holdings has a consensus price target of $271.13, signalling upside risk potential of 12.37%. On the other hand Illumina has an analysts' consensus of $115.55 which suggests that it could grow by 51.02%. Given that Illumina has higher upside potential than Labcorp Holdings, analysts believe Illumina is more attractive than Labcorp Holdings.

Labcorp Holdings has a beta of 0.826, which suggesting that the stock is 17.43% less volatile than S&P 500. In comparison Illumina has a beta of 1.349, suggesting its more volatile than the S&P 500 by 34.945%.

Labcorp Holdings has a quarterly dividend of $0.72 per share corresponding to a yield of 1.19%. Illumina offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Labcorp Holdings pays 32.59% of its earnings as a dividend. Illumina pays out -- of its earnings as a dividend. Labcorp Holdings's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Labcorp Holdings quarterly revenues are $3.3B, which are larger than Illumina quarterly revenues of $1.1B. Labcorp Holdings's net income of $212.8M is higher than Illumina's net income of $187M. Notably, Labcorp Holdings's price-to-earnings ratio is 27.89x while Illumina's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Labcorp Holdings is 1.54x versus 2.79x for Illumina. Usually stocks with elevated PS ratios are considered overvalued.

Waters has a net margin of 6.36% compared to Labcorp Holdings's net margin of 26.52%. Labcorp Holdings's return on equity of 9.01% beat Waters's return on equity of 43.99%.

Labcorp Holdings has a consensus price target of $271.13, signalling upside risk potential of 12.37%. On the other hand Waters has an analysts' consensus of $390.59 which suggests that it could grow by 14.26%. Given that Waters has higher upside potential than Labcorp Holdings, analysts believe Waters is more attractive than Labcorp Holdings.

Labcorp Holdings has a beta of 0.826, which suggesting that the stock is 17.43% less volatile than S&P 500. In comparison Waters has a beta of 1.138, suggesting its more volatile than the S&P 500 by 13.849%.

Labcorp Holdings has a quarterly dividend of $0.72 per share corresponding to a yield of 1.19%. Waters offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Labcorp Holdings pays 32.59% of its earnings as a dividend. Waters pays out -- of its earnings as a dividend. Labcorp Holdings's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Labcorp Holdings quarterly revenues are $3.3B, which are larger than Waters quarterly revenues of $872.7M. Labcorp Holdings's net income of $212.8M is lower than Waters's net income of $231.4M. Notably, Labcorp Holdings's price-to-earnings ratio is 27.89x while Waters's PE ratio is 31.92x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Labcorp Holdings is 1.54x versus 6.88x for Waters. Usually stocks with elevated PS ratios are considered overvalued.